The ability of grafted human sympathetic neurons to synthesize and store dopamine: A potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease

Experimental Neurology

Volumn 188, Issue 1, 2004, Pages 65-73

  Nakao, Naoyuki ^a   Shintani Mizushima, Aki ^a   Kakishita, Koji ^a   Itakura, Toru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aromatic L amino acid decarboxylase; Cell therapy; Transplantation; Tyrosine hydroxylase; Vesicular monoamine transporter 2

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BENSERAZIDE; CARBIDOPA; CARRIER PROTEIN; CYCLOSPORIN A; DOPAMINE; LEVODOPA; RESERPINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ADOPTIVE IMMUNOTHERAPY; ADULT; ANIMAL MODEL; ARTICLE; ATTENUATION; AUTOGRAFT; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SYMPATHETIC NERVE CELL; XENOGRAFT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; DENERVATION; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; GANGLIA, SYMPATHETIC; GRAFT SURVIVAL; HUMANS; LEVODOPA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEURONS; NEUROPEPTIDES; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RESERPINE; TRANSPLANTATION, HETEROLOGOUS; TYROSINE 3-MONOOXYGENASE; UP-REGULATION; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 2942513693     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.03.004     Document Type: Article

References (28)

1. Arai R., Karasawa N., Geffard M., Nagatsu T., Nagatsu I. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-dopa in the rat, with special reference to the involvement of aromatic L-amino acid decarboxylase. Brain Res. 667:1994;295-299
2. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Oertel W.H., Quinn N.P., Rehncrona S., Lindval O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain. 123:2000;1380-1390
3. Christenson J.W., Dairman W., Udenfriend S. On the identity of DOPA decarboxylation and 5-hydroxytryptophan decarboxylase. Proc. Natl. Acad. Sci. 69:1972;343-347
4. Defer G.L., Widner H., Marie R.M., Remy P., Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov. Disord. 14:1999;572-584
5. Erickson J.D., Eiden L.E. Functional identification and molecular cloning of a human brain vesicular monoamine transporter. J. Neurochem. 61:1993;2314-2317
6. Erickson J.D., Eiden L.E., Hoffman B.J. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Pro. Natl. Acad. Sci. U.S.A. 89:1992;10993-10997
7. Fabbrini G., Juncos J., Mouradian M.N., Serrati C., Chase T.N. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann. Neurol. 21:1987;370-376
8. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J.X., Lone T., Zhang Y.B., Snyder J.A., Wells T.H., Raming L., Thompson J.C., Mazziotta S.C., Huang S.T., Grafton D., Brooks G., Sawle G., Schroter G., Ansari A.A. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327:1992;1549-1555
9. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Trasnsplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:2001;710-719
10. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.H., Vingerhoets F.J., Snow B.J., Calne D., Gauger L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388
11. Hagell P., Schrag A., Piccini P., Jahanshahi M., Brown R., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Odin P., Wenning G.K., Morrish P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain. 122:1999;11121-11132
12. Hefti F., Melamed E., Wurtman R.J. The site of dopamine formation in rat striatum after L-dopa administration. J. Pharmacol. Exp. Ther. 217:1981;189-197
13. Juorio A.V., Li X.-M., Walz W., Patterson I.A. Decarboxylation of L-dopa by cultured mouse astrocytes. Brain Res. 626:1993;306-309
14. Koike T., Takashima A. Clonal variability of PC12 pheochromocytoma cells with respect to catecholamine biosynthesis. J. Neurochem. 42:1986;1472-1475
15. Langston J.W., Widner H., Goets C.G., Brooks D., Fahn S., Freeman T., Watts R. Core assessment program for intracerebral transplantation (CAPIT). Mov. Disord. 7:1992;2-13
16. Lee W.-Y., Chang J.-W., Nemeth N.L., Kang U.-J. Vesicular monoamine trasnporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-diihydroxyphenylalanine administration in parkinsonian rats. J. Neurosci. 19:1999;3266-3274
17. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D., Bjorklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577
18. Lindvall O., Sawle G., Widner H., Rothwell J.C., Bjorklund A., Brooks D., Brundin P., Frackowiak R., Marsden C.D., Odin P. Evidence of long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:1994;172-180
19. Marsden C.D. Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 57:1994;672-681
20. Mura A., Jackson D., Manley M.S., Young S.J., Groves P.M. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-dopa to dopamine. Brain Res. 704:1995;51-60
21. Mura A., Linder J.C., Young S.J., Groves P.M. Striatal cells containing aromatic L-amino acid decarboxylase: an immunohistochemical comparison with other classes of striatal neurons. Neuroscience. 98:2000;501-511
22. Nakao N., Frodl E.M., Duan W.-M., Widner H., Brundin P. Overexpressing CuZn-superoxide dismutase enhances transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:1995;226-231
23. Nakao N., Itakura T., Uematsu Y., Komai N. Transplantation of cultured sympathetic ganglionic neurons into parkinsonian rat brain: survival and function of graft. Acta Neurochir. (Wien). 133:1995;61-67
24. Nakao N., Kakishita K., Uemastu Y., Yoshimasu T., Bessho T., Nakai K., Naito Y., Itakura T. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease. J. Neurosurg. 95:2001;275-284
25. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54:2003;403-414
26. Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., Geny C., Samson Y., Hantraye P., Jeny R. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain. 117:1994;487-499
27. Schmidt R.H., Bjorklund A., Stenevi U., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspensions: III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl. 522:1983;19-28
28. Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavii B., Hagell P., Jahanshahi M., Sawle G., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:1997;95-107